Home/Sedivention/Jakob Wintermeyer

JW

Jakob Wintermeyer

Corporate Fundraising / Investor Management

Therapeutic Areas

Sedivention Pipeline

Drug	Indication	Phase
Cryo-ablation Therapy for Obesity	Obesity	Pre-clinical

Leadership Team at Sedivention

Dr.-Ing. Andreas Bröcker

CEO, Co-Founder

Dr. med. Ute Nollert

André Burch, EMBA

Ann-Kathrin Waldmann

Business Development / Business Intelligence

Marketing Manager

View full Sedivention profile